首页> 外文期刊>Molecular pharmaceutics >Facile Construction of Chloroquine Containing PLGA-Based pDNA Delivery System for Efficient Tumor and Pancreatitis Targeting in Vitro and in Vivo
【24h】

Facile Construction of Chloroquine Containing PLGA-Based pDNA Delivery System for Efficient Tumor and Pancreatitis Targeting in Vitro and in Vivo

机译:基于PLGA的pDNA递送体系氯喹的体内和体外靶向高效构建。

获取原文
获取原文并翻译 | 示例
           

摘要

Chloroquine diphosphate (CQ) was ingeniously used to take place of phosphate salt in traditional calcium phosphate coprecipitation method for pDNA transfection. With multiple roles of CQ in the novel Ca-CQ-pDNA complex including pDNA compaction and assistance in lysosome escape, the transfection efficiency of the pDNA was significantly increased relative to the traditional method. CQ did not intercalate into the DNA double helix as free CQ did, which was probably ascribed to the prior mixing of the pDNA with high concentration of calcium chloride. In order to construct efficacious vector for in vivo gene delivery, Ca-CQ-pDNA-PLGA-NPs was designed and prepared. With entrapment efficiency, particle size and pDNA integrity as screening conditions, the optimal prescription was obtained and CaPi-pDNA-PLGA-NPs made with classic calcium phosphate coprecipitation method after optimization was also prepared as control to systematically study the role of CQ in the novel vector. Physical characters of the vectors were comprehensively studied using TEM, DSC, and XRD. The safety of the vector both in vitro and in vivo was evaluated using MTT, hemolysis test, and histological sections. The Ca-CQ-pDNA-PLGA-NPs dramatically enhanced the gene tranfection efficiency in Human Embryonic kidney HEK293 cells compared with the CaPi-pDNA-PLGA-NPs and presented an increasing gene transfection for up 144 h. The relative fast release of the CQ compared with pDNA from the nanoparticles was responsive for the increased transfection. The Did-labeled-Ca-CQ-pDNA-PLGA-NPs exhibited excellent tumor targeting efficiency and sustained circulation time in CT26 mouse model. The Ca-CQ-pDNA-PLGA-NP loaded with the plasmid pVITRO2 expressing mSurvivin-T34A protein gave 70% tumor inhibition rate, which was partially ascribed to CQ. The Ca-CQ-pDNA-PLGA-NPs showed high targeting efficiency in C57 acute pancreatitis model. In all, the Ca-CQ-pDNA-PLGA-NP was a promising candidate for targeted gene delivery to both tumor and pancreatitis.
机译:在传统的磷酸钙共沉淀方法中,氯磷酸二磷酸酯(CQ)巧妙地用于代替磷酸盐,用于pDNA转染。由于CQ在新型Ca-CQ-pDNA复合物中具有多种作用,包括pDNA压缩和溶酶体逃逸的辅助作用,相对于传统方法,pDNA的转染效率显着提高。 CQ没有像游离CQ那样插入DNA双螺旋中,这可能是由于先将pDNA与高浓度的氯化钙混合。为了构建用于体内基因递送的有效载体,设计并制备了Ca-CQ-pDNA-PLGA-NP。以包封率,粒径和pDNA完整性为筛选条件,确定了最佳处方,并采用优化后的经典磷酸钙共沉淀法制备的CaPi-pDNA-PLGA-NPs作为对照,系统地研究了CQ在新型中的作用。向量。使用TEM,DSC和XRD对载体的物理特性进行了全面研究。使用MTT,溶血试验和组织学切片评估了载体在体外和体内的安全性。与CaPi-pDNA-PLGA-NPs相比,Ca-CQ-pDNA-PLGA-NPs显着提高了人胚肾HEK293细胞的基因转染效率,并且在144小时内呈现出增加的基因转染。与来自纳米颗粒的pDNA相比,CQ的相对快速释放对增加的转染有响应。在CT26小鼠模型中,Did标记的Ca-CQ-pDNA-PLGA-NPs表现出优异的肿瘤靶向效率和持续的循环时间。载有表达mSurvivin-T34A蛋白的质粒pVITRO2的Ca-CQ-pDNA-PLGA-NP的肿瘤抑制率为70%,这部分归因于CQ。 Ca-CQ-pDNA-PLGA-NPs在C57急性胰腺炎模型中显示出高靶向效率。总体而言,Ca-CQ-pDNA-PLGA-NP是靶向基因向肿瘤和胰腺炎的有前途候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号